| Product Code: ETC9932660 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Secukinumab Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Secukinumab Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Secukinumab Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Arab Emirates (UAE) Secukinumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis and other autoimmune diseases in the UAE |
4.2.2 Growing awareness about the effectiveness of secukinumab in treating such conditions |
4.2.3 Favorable government initiatives and healthcare policies supporting the use of advanced biologic treatments |
4.3 Market Restraints |
4.3.1 High cost of secukinumab treatment limiting accessibility for a significant portion of the population |
4.3.2 Limited reimbursement options for secukinumab in the UAE healthcare system |
4.3.3 Competition from other biologic drugs in the market |
5 United Arab Emirates (UAE) Secukinumab Market Trends |
6 United Arab Emirates (UAE) Secukinumab Market, By Types |
6.1 United Arab Emirates (UAE) Secukinumab Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Sensoready Pen, 2021- 2031F |
6.1.4 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Prefilled Syringe, 2021- 2031F |
6.1.5 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Powder for Solution, 2021- 2031F |
6.2 United Arab Emirates (UAE) Secukinumab Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F |
6.2.3 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Arab Emirates (UAE) Secukinumab Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 United Arab Emirates (UAE) Secukinumab Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Ankylosing Spondylitis, 2021- 2031F |
6.4.3 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.4.4 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Plaque Psoriasis, 2021- 2031F |
6.4.5 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Arab Emirates (UAE) Secukinumab Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Arab Emirates (UAE) Secukinumab Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United Arab Emirates (UAE) Secukinumab Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 United Arab Emirates (UAE) Secukinumab Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Secukinumab Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Secukinumab Market Imports from Major Countries |
8 United Arab Emirates (UAE) Secukinumab Market Key Performance Indicators |
8.1 Patient adherence rate to secukinumab treatment |
8.2 Number of healthcare providers prescribing secukinumab |
8.3 Rate of new diagnoses of psoriasis and autoimmune diseases in the UAE |
9 United Arab Emirates (UAE) Secukinumab Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Secukinumab Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Secukinumab Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Secukinumab Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 United Arab Emirates (UAE) Secukinumab Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 United Arab Emirates (UAE) Secukinumab Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 United Arab Emirates (UAE) Secukinumab Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Arab Emirates (UAE) Secukinumab Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Secukinumab Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Secukinumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here